Effects of C-type natriuretic peptide on renal vasoconstriction in dogs

European Journal of Pharmacology

Volumn 338, Issue 2, 1997, Pages 131-134

  Yoshida, Kozo ^a   Yamagata, Tsuyoshi ^a   Tomura, Yuichi ^a   Suzuki Kusaba, Mizue ^a   Yoshida, Makoto ^a   Hisa, Hiroaki ^a   Satoh, Susumu ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Angiotensin II; CNP (C type natriuretic peptide); Dog; Kidney; Norepinephirine; Vasoconstriction

Indexed keywords

ANGIOTENSIN; NATRIURETIC PEPTIDE TYPE C; NORADRENALIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION RATE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; URINE FLOW RATE; VASOCONSTRICTION;

EID: 0030662008     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)81940-1     Document Type: Article

References (13)

1. Amin J., Carretero O.A., Ito S. Mechanisms of action of atrial natriuretic factor and C-type natriuretic peptide. Hypertension. 27:1996;684-687.
2. Charles C.J., Espiner E.A., Richards A.M., Nicholls M.G., Yandle T.G. Biological actions and pharmacokinetics of C-type natriuretic peptide in conscious sheep. Am. J. Physiol. 268:1995;R201-R207.
3. Clavell A.L., Stingo A.J., Wei C.-M., Heublein D.M., Burnett Jr. J.C. C-type natriuretic peptide: A selective cardiovascular peptide. Am. J. Physiol. 264:1993;R290-R295.
4. Goetz K.L. Physiology and pathology of atrial peptides. Am. J. Physiol. 254:1988;E1-E15.
5. Hisa H., Tomura Y., Yamagata T., Satoh S. Atrial natriuretic peptide suppresses renal vasoconstriction induced by angiotensin II and norepinephrine in dogs. Eur. J. Pharmacol. 222:1992;265-271.
6. Nir A., Beers K.W., Clavell A.L., Wei C.-M., Heublein D.M., Dousa T.P., Burnett J.C. Jr. CNP is present in canine renal tubular cells and secreted by cultured opossum kidney cells. Am. J. Physiol. 267:1994;R1653-R1657.
7. Sano T., Imura R., Morishita Y., Matsuda Y., Yamada K. HS-142-1, a novel polysaccharide of microbial origin, specifically recognizes guanylyl cyclase-linked ANP receptor in rat glomeruli. Life Sci. 51:1992;1445-1451.
8. Stingo A.J., Clavell A.L., Aarhus L. L, Burnett J.C. Jr. Cardiovascular and renal actions of C-type natriuretic peptide. Am. J. Physiol. 262:1992;H308-H312.
9. Sudoh T., Minamino N., Kangawa K., Matsuo H. C-type natriuretic peptide (CNP): a new member of the natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun. 168:1990;863-870.
10. Takagi H., Takahara A., Tomura Y., Yamagata T., Hisa H., Satoh S. Effects of nifedipine, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate hydrochloride and atrial natriuretic peptide on endothelin-induced antinatriuresis in dogs. J. Pharmacol. Exp. Ther. 267:1993;456-461.
11. Terada Y., Tomita K., Nonoguchi H., Yang T., Marumo F. PCR localization of C-type natriuretic peptide and B-type receptor mRNAs in rat nephron segments. Am. J. Physiol. 267:1994;F215-F222.
12. Tomura Y., Yamagata T., Hisa H., Satoh S. Effects of ANP on adrenergically induced norepinephrine release and vasoconstriction in the dog kidney. Eur. J. Pharmacol. 199:1991;255-258.
13. Tomura Y., Hisa H., Satoh S. Effects of atrial natriuretic peptide on angiotensin II-induced antinatriuresis in anesthetized dogs. Biol. Pharm. Bull. 18:1995;1211-1214.